INS and Hyperinsulinemia: In short, we need treatments that reverse the hyperinsulinemia resulting from impairments in insulin signaling or glucose metabolism, as hyperinsulinemia can hyperactivate uninhibited or partially inhibited insulin‐signaling pathways and provoke adverse effects.